Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Amortization (2019 - 2023)

ADC Therapeutics has reported Amortization over the past 5 years, most recently at $2.0 billion for Q3 2023.

  • Quarterly results put Amortization at $2.0 billion for Q3 2023, changed 0.05% from a year ago — trailing twelve months through Sep 2023 was $2.0 billion (changed 0.05% YoY), and the annual figure for FY2022 was $2.0 billion, changed 0.05%.
  • Amortization reached $2.0 billion in Q3 2023 per ADCT's latest filing, roughly flat from $2.0 billion in the prior quarter.
  • Across five years, Amortization topped out at $2.0 billion in Q1 2023 and bottomed at $549922.0 in Q4 2019.
  • Median Amortization over the past 5 years was $2.0 billion (2022), compared with a mean of $1.3 billion.
  • The largest annual shift saw Amortization soared 205842.59% in 2022 before it increased 0.05% in 2023.
  • Over 5 years, Amortization stood at $549922.0 in 2019, then skyrocketed by 78.4% to $981056.0 in 2020, then increased by 0.08% to $981827.0 in 2021, then skyrocketed by 205842.59% to $2.0 billion in 2022, then grew by 0.05% to $2.0 billion in 2023.
  • Business Quant data shows Amortization for ADCT at $2.0 billion in Q3 2023, $2.0 billion in Q2 2023, and $2.0 billion in Q1 2023.